Champions Oncology Inc expected to post a loss of 1 cent a share - Earnings Preview

Champions Oncology

09/12/2022 21:35

* Champions Oncology Inc  CSBR.OQ   CSBR.O  is expected
to show a
rise in quarterly revenue when it reports  results on December
12 (estimated). 
    * The Baltimore Maryland-based  company is expected to
report  a
17.0% increase in revenue to $13.789 million from $11.79 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Champions Oncology
Inc is
for a loss of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Champions
Oncology Inc is $15​, above​ its last closing price of $6.64.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jul. 31 2022  0.01        0.01       -0.02     Missed  -300
 Apr. 30 2022              0.03       -0.03     Missed  -220
 Jan. 31 2022  0.02        0.03       0.05      Beat    100​
 Oct. 31 2021  0.01        0.01       0.02      Beat    300
 ​​Jul.        0.01        0.01       -0.01     Missed  -200
 31 2021                                                
 Apr. 30 2021  0.00        0.00       -0.04     Missed  ​
 Jan. 31 2021  0.00        0.01       0.05      Beat    649.6
 Oct. 31 2020  0.00        0.00       0.00      Met     
 This summary was machine generated December 9 at 21:35 GMT.  All
figures in US dollars  unless otherwise stated